Neuroaid for improving recovery after ischemic stroke
Referencias
Additional references
Atkins D, Best D, Briss PA, Eccles M, Falck‐Ytter Y, Flottorp S, GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490.
Chan HY, Stanton LW. A pharmacogenomic profile of human neural progenitors undergoing differentiation in the presence of the traditional Chinese medicine NeuroAiD. Pharmacogenomics Journal 2016;16(5):461‐71.
Chen C, Venketasubramanian N, Gan RN, Lambert C, Picard D, Chan BP, et al. Danqi Piantang Jiaonang (DJ), a traditional Chinese medicine, in poststroke recovery. Stroke 2009;40(3):859‐63.
Chen CL, Young SH, Gan HH, Singh R, Lao AY, Baroque AC, et al. Chinese medicine Neuroaid efficacy on stroke recovery: a double‐blind, placebo‐controlled, randomized study. Stroke 2013;44(8):2093‐100.
Chen CL, Venketasubramanian N, Lee CF, Wong KS, Bousser MG, CHIMES Study Investigators. Effects of MLC601 on early vascular events in patients after stroke: the CHIMES study. Stroke 2013;44(12):3580‐3.
Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008;371:1612‐23.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315(7109):629‐34.
Gan R, Lambert C, Lianting J, Chan ES, Venketasubramanian N, Chen C, et al. Danqi Piantan Jiaonang does not modify hemostasis, hematology, and biochemistry in normal subjects and stroke patients. Cerebrovascular Diseases 2008;25:450‐6.
GRADE Working Group. GRADEpro GDT. Hamilton (ON): McMaster University, (accessed 31 May 2017).
Heurteaux C, Gandin C, Borsotto M, Widmann C, Brau F, Lhuillier M, et al. Neuroprotective and neuroproliferative activities of Neuroaid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo. Neuropharmacology 2010;58:987‐1001.
Higgins JP, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org/.
Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44(3):870‐947.
Kong KH, Wee SK, Ng CY, Chua K, Chan KF, Venketasubramanian N, et al. A double‐blind, placebo‐controlled, randomized, phase II pilot study to investigate the potential efficacy of the traditional Chinese medicine Neuroaid (MLC 601) in enhancing recovery after stroke (TIERS). Stroke 2005;36(9):1984‐7.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine 2009;6(7):e1000100.
Lindsay P, Furie KL, Davis SM, Donnan GA, Norrving B. World Stroke Organization global stroke services guidelines and action plan. International Journal of Stroke 2014;9(Suppl A100):4‐13.
Pandian JD, Liu M, Misbach J, Venketasubramanian N. Alternative therapies for stroke treatment in Asia. International Journal of Stroke 2011;6(6):541‐3.
Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, et al. 2015 AHA/ASA focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015;46:3024‐39.
Quintard H, Borsotto M, Veyssiere J, Gandin C, Labbal F, Widmann C, et al. MLC901, a traditional Chinese medicine protects the brain against global ischemia. Neuropharmacology 2011;61:622‐31.
The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, Council on Peripheral Vascular Disease, Council on Nutrition, Physical Activity, Metabolism. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44(7):2064‐89.
Shahripour RB, Shamsaei G, Pakdaman H, Majdinasab N, Nejad EM, Sajedi SA, et al. The effect of NeuroAiDTM (MLC601) on cerebral blood flow velocity in subjects' post brain infarct in the middle cerebral artery territory. European Journal of Internal Medicine 2011;22:509‐13.
Sheng K, Cai H, Gao Y. Danqi piantan jiaonang for stroke sequela in 130 patients. Shanxi Journal of Traditional Chinese Medicine 2008;24(2):23.
Siow CH. Neuroaid in stroke recovery. European Neurology 2008;60:264‐6.
Sulter G, Steen C, De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999;30(8):1538‐41.
Tang Q, Xing YL, Wang WH, Qu QS, Zhu WZ, Sheng GB. Phase Ⅱ clinical trial report of Danqi Piantan capsule in stroke with qi deficiency and blood stasis syndrome. Zhong Guo Zhong Yi Yao Ke Ji 2003;10:69‐71.
Tang CD. The clinical observation of treating cerebral infarction with Danqi Piantan Jiaonang. Hubei Journal of Traditional Chinese Medicine 2004;26(5):37.
Uyttenboogaart M, Stewart RE, Vroomen PC, De Keyser J, Luijckx GJ. Optimizing cutoff scores for the Barthel index and the modified Rankin scale for defining outcome in acute stroke trials. Stroke 2005;36(9):1984‐7.
Venketasubramanian N, Lee CF, Young SH, Tay SS, Umapathi T, Lao AY, et al. Prognostic factors and pattern of long‐term recovery with MLC601 (NeuroAiD™) in the Chinese Medicine NeuroAiD Efficacy on Stroke Recovery ‐ Extension Study. Cerebrovascular Diseases 2017;43:36‐42.
WHO Task Force. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on stroke and other cerebrovascular disorders. Stroke 1989;20(10):1407‐31.
Young SHY, Zhao Y, Koh A, Singh R, Chan BP, Chang HM, et al. Safety profile of MLC601 (Neuroaid) in acute ischemic stroke patients: a Singaporean substudy of the Chinese medicine Neuroaid efficacy on stroke recovery study. Cerebrovascular Diseases 2010;30:1‐6.
Zheng HZ, Zhao XF. Research progress about the efficacy and safety of Danqi Piantan Jiaonang. Chinese Journal of Acupuncture and Moxibustion 2012;1(2):70‐4.
